No mutation in the 13 other genes covered by the TruSight Tumor 15 gene panel (Additional file 2: Table S2) was observed in any case, except for the BRAF mutation detected in the single primary tumor being KRAS-negative. This evidence concerns the gene BRAF and neoplasm.